Nurse Prescribing in Mental Health

Nurse Prescribing in Mental Health

Volumn , Issue , 2009, Pages 1-206

  Jones, Adrian ^a  

^a GLYNDWR UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651064043     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444311624     Document Type: Book

References (430)

1. Age Concern (2008). The Age Agenda Conference 2008. Age Concern England, London. Accessed at: http://www.ageconcern.org.uk/AgeConcern/3D21CD1299E04A97AAB7B91EF45F5D16.asp
2. Allsop A., Brooks L., Bufton L., Carr C., Courtney Y., Dale C., Pittard S., & Thomas C. (2005) Supplementary prescribing in mental health and learning disabilities. Nursing Standard 19(30), 54-58.
3. An Bord Altranais (2005). Review of Nurses and Midwives in the Prescribing and Administration of Medicinal Products. ABA, Dublin.
4. Anderson P. & Baumberg B. (2006) Alcohol in Europe: A Public Health Perspective. Institute of Alcohol Studies, London.
5. Andreasen N.C. & Carpenter W.T. (1993) Diagnosis and classification of schizophrenia. Schizophrenia Bulletin 19, 199-214.
6. Angermeyer M.C., Boitz K. & Loffler W. (1999) Attitude of family to clozapine. Psychiatric Praxis 26, 181-187.
7. Appleby L. (2006) Avoidable Deaths. The University of Manchester, Manchester.
8. Assmann G., Schulte H., von Eckardstein A. & Huang Y. (1996). High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 124(Suppl), S11-S20.
9. Audit Commission (2001). A spoonful of sugar -medicines management in NHS hospitals. Accessed at: http://www.audit-commission.gov.uk
10. Avery J.A. & Pringle M. (2005) Extended prescribing by UK nurses and pharmacists. British Medical Journal 331(7526), 1154-1155.
11. Babiker I.E. (1986) Non-compliance in schizophrenia. Psychiatric Developments 4, 329-337.
12. Bailey K. (1999). Framework for prescriptive practice (Chapter 13). In: C. Shea, L. Pelletier, E. Poster, G. Stuart & M. Verhey (Eds.). Advanced Practice Nursing in Psychiatric and Mental Health Care. Mosby, New York.
13. Baker A., Boggs T.G. & Lewin T.J. (2001) Randomized controlled trial of brief cognitivebehavioural interventions among regular users of amphetamine. Addiction 96(9), 1279-1287.
14. Baker J.A., Lovell K., Harris N. & Campbell M. (2007) Multidisciplinary consensus of best practice for pro re nata (PRN) psychotropic medications within acute mental health settings:a Delphi study. Journal of Psychiatric and Mental Health Nursing 14, 478-484.
15. Banning M. (2004) Nurse prescribing, nurse education and related research in the United Kingdom: a review of the literature. Nurse Education Today 24, 420-427.
16. Barcroft S. (2005) Nurse prescribing in substance misuse. Accessed at: http://www.nta.nhs.uk/publications/documents/nta_nurse_prescribing_in_substance_misuse_may_2005.pdf
17. Barker P.J., Jackson S. & Stevenson C. (1999). The need for psychiatric nursing: towards a multidimensional theory of caring. Nursing Inquiry 6(2), 103-111.
18. Barker P.J. & Walker L. (2000) Nurses' perceptions of multidisciplinary teamwork in acute psychiatric settings. Journal of Psychiatric and Mental Health Nursing 7, 539-546.
19. Barlow M., Majorrian K. & Jones M. (2008) Nurse prescribing in an Alzheimer's disease service:a reflective account. Mental Health Practice 11, 32-35.
20. Barnes T.R.E. (1989). A rating scale for drug-induced akathisia, British Journal of Psychiatry 154, 672-676.
21. Bazire S. (2007) Psychotropic Drug Directory. Fivepin, Wiltshire.
22. Beattie A. (1995). War and peace amongst the health tribes. In: K. Soothill, L. Mackay & C. Webb (Eds.). Interpersonal relations in health care. Edward Arnold, London.
23. Beck A., Steer R. & Brown G. (1987) Beck Depression Inventory 2. The Psychological Corporation, San Antonio.
24. Bedi N., Chilvers C., Churchill R., et al. (2000) Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial. British Journal of Psychiatry 177, 312-318.
25. Bennett J., Done J. & Hunt B. (1995) Assessing the side effects of antipsychotic drugs: a survey of CPN practice. Journal of Psychiatric and Mental Health Nursing 2, 177-182.
26. Benson K.L. (2006) Psychiatric Clinics North America 26, 1033-45.
27. Berger G.E., Proffitt T. & Wood S. (2004). Ethyl-eicosapentaenoic acid supplementation in early psychosis: a double-blind randomised placebo-controlled add on study in 80 drug naïve first episode psychosis patients. International Journal of Neuropsychopharmacology 8(1), S422.
28. Berry D., Courtenay M. & Bersellini E. (2006) Attitudes towards, and information needs in relation to, supplementary nurse prescribing in the UK: an empirical study. Journal of Clinical Nursing 15(1), 22-28.
29. Blenkinsopp A., Bond C., Britten N., et al. (1997) From compliance to concordance: achieving shared goals in medicine taking. A working party report. Royal Pharmaceutical Society of Great Britain, London.
30. Blenkiron P. (1998). Referral to a psychiatric clinic: what do patients expect? International Journal of Health Care Quality Assurance 11, 188-192.
31. Bowles N. & Jones A. (2005) Whole systems working and acute inpatient psychiatry: an exploratory study. Journal of Psychiatric and Mental Health Nursing 12, 283-289.
32. Bradley E., Campbell P. & Nolan P. (2005). Nurse prescribers: who are they and how do they perceive their role? Journal of Advanced Nursing 51(5), 439-448.
33. Bradley E., Blackshaw C. & Nolan P. (2006) Nurse lecturers' observations on aspects of nurse prescribing training. Nurse Education Today 26(7), 538-544.
34. Bradley E. & Nolan P. (2007) Impact of nurse prescribing: a qualitative study. Journal of Advanced Nursing 59, 120-128.
35. Brandon D. (1991) Innovation Without Change: Consumer Power in Psychiatric Services. Macmillan Education.
36. Brimblecombe N. (2005) The changing relationship between mental health nurses and psychiatrists in the United Kingdom. Journal of Advanced Nursing 49(4), 344-353.
37. Brimblecombe N., Tingle A., Tumore R. et al. (2007) Implementing holistic practices in mental health nursing: a national consultation. International Journal of Nursing Studies 44(3), 339-348.
38. BNF (2008). BNF Edition 55. British Medical Association, London. Accessed at: http://www. bnf.org.uk
39. Brooten D., Naylor M.D. & York R. (2002) Lessons learned from testing the quality cost model of advanced practice nursing (APN) transitional care. Journal of Nursing Scholarship 34(4), 369-375.
40. Brooks N., Otway C., Rashid C., et al. (2001) The patient's view: the benefits and limitations of nurse prescribing. British Journal of Community Nursing 6, 342-348.
41. Brown S. (1997) Excess mortality of schizophrenia. A meta-analysis. British Journal of Psychiatry 171, 502-508.
42. Brown S., Inskip H. & Barraclough B. (2000). Causes of excess mortality of schizophrenia. British Journal of Psychiatry 177, 212-217
43. Bruce M.S. (1990). The anxiogenic effects of caffeine. Postgraduate Medical Journal 66, S18-S24.
44. Brugha T.S., Bebbington P.E. & Jenkins R. (1999a) A difference that matters: comparisons of structured and semi-structured psychiatric diagnostic interviews in the general population. Psychological Medicine 29(5), 1013-1020.
45. Brugha T.S., Nienhuis F.J., Bagchi D., Smith J. & Meltzer H. (1999b). The survey form of SCAN: the feasibility of using experienced lay survey interviewers to administer a semi-structured systematic clinical assessment of psychotic and non-psychotic disorders. Psychological Medicine 29, 703-711.
46. Bryne M.K., Deane F.P. & Coombs T. (2005) Nurse's beliefs and knowledge about medications are associated with their difficulties using patient treatment adherence strategies. Journal of Mental Health 14, 513-521.
47. Buchan J. & Calman (2005). Skill mix and policy changes in the health workforce: nurses in advanced roles. OECD Health Working Papers No. 17. OECD Publishing, Paris.
48. Burns T. & Lloyd H. (2004). Is a team approach based on staff meetings cost effective in the delivery of mental health care? Current Opinion in Psychiatry 17(4), 311-314.
49. Burris K.D., Molski T.F., Xu C., et al. (2002) Aripiprazole, a novel antipsychotic, is a highaffinity partial agonist at human dopamine D2 receptors. The Journal of Pharmacology and Experimental Therapeutics 302, 381-389.
50. Bushe S. & Leonard B. (2004). Association between atypical antipsychotic agents and type 2 diabetes:review of prospective clinical data. British Journal of Psychiatry Supplement 47, S87-S93
51. Campbell C.D., Musil C.M. & Zausziewski J.A. (1998) Practice patterns of advanced practice psychiatric nurses. Journal of American Psychiatric Nurses Association 4(4), 111-120.
52. Carr N., Bayliss J. & Nolan P. (2002) Report of an Educational Visit to the USA. Perceptions on Nurse Prescribing. South Staffordshire NHS Trust.
53. Carrillo J.A., Herraiz A.G., Ramos S.I., et al. (1998) Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients. Journal of Clinical Psychopharmacology 18, 311-316.
54. Carrillo J.A., Herraiz A.G., Ramos S.I., et al. (2003) Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady state concentration of olanzapine. Journal of Clinical Psychopharmacology 23, 119-127.
55. Carroll K.M., Ball S.A. & Martino S. (2008) Computer-assisted delivery of cognitive behavioural therapy for addiction: a randomised trial of CBT4CBT. American Journal of Psychiatry 165, 881-888.
56. Chadwick P., Birchwood M. & Trower P. (1996) Cognitive therapy for delusions, voices and paranoia. John Wiley & Sons, Chichester.
57. Chaplin R. & Kent A. (1998) Informing patients about tardive dyskinesia. British Journal of Psychiatry 172, 78-81.
58. Chrzanowski W.K., Marcus R.N., Torbeyns A., et al. (2006) Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. Psychopharmacology 189, 259-266.
59. Coffey M. & Jenkins E. (2002) Power and control: forensic community mental health nurses' perceptions of team working, legal sanction and compliance. Journal of Psychiatric and Mental Health Nursing 9, 521-529.
60. College of Nurses of Ontario (2005a). Legislation and Regulation. RHPA: Scope of Practice, Controlled Acts Model. Reference document. College of Nurses of Ontario, Toronto.
61. College of Nurses of Ontario (2005b). Practice Standard: Medication. College of Nurses of Ontario, Toronto.
62. Connolly M. & Kelly C. (2005) Lifestyle and physical health in schizophrenia. Advances in Psychiatric Treatment 11, 125-132.
63. Cookson J., Taylor D. & Katona C. (2002) Use of Drugs in Psychiatry. Gaskell, London.
64. Cooney J.L., Cooney N.L., Pilkey D.T., et al. (2003) Effects of nicotine deprivation on urges to drink and smoke in alcoholic smokers. Addiction 98, 913-921.
65. Cooper J.E. (1994) ICD-10 Classification of Mental and Behavioural Disorders. Churchill Livingstone, Edinburgh.
66. Cooper N., Blackwell D., Taylor G., et al. (2000) Pharmacists' perceptions of nurse prescribing of emergency contraception. British Journal of Community Nursing 5(3), 126-131.
67. Cott C. (1998) Structure and meaning in multidisciplinary teamwork. Sociology of Health and Illness 20, 848-873.
68. Courtenay M. & Carey N. (2007) A review of the impact and effectiveness of nurse-led care in dermatology. Journal of Clinical Nursing 16(1), 122-128.
69. Courtenay M. & Carey N. (2008) Nurse independent prescribing and nurse supplementary prescribing practice: national survey. Journal of Advanced Nursing 61(3), 291-299.
70. Courtenay M., Carey N., James J., et al. (2007) An evaluation of a specialist nurse prescriber on diabetes in-patient service delivery. Practical Diabetes International 24, 1-6.
71. Craddock N., Antebi A., Attenburrow M.-J., et al. (2008) Wake-up call for British psychiatry. British Journal of Psychiatry 193, 6-9.
72. Cramer J. & Rosenheck R. (1999) Enhancing medication compliance for people with serious mental illness. Journal of Nervous and Mental Disease 187(1), 53-55.
73. Crisp A.H., Gelder M., Goddard E., et al. (2005) Stigmatization of people with mental illness:a follow-up study within the changing minds campaign of the Royal College of Psychiatrists. World Psychiatry 4, 106-134.
74. CSIP-NIMHE (2006). Our choices in mental health: a framework for improving choice for people who use mental health services and their carers. CSIP-NIMHE, London.
75. Curtis L. & Netten A. (2007) The costs of training a nurse practitioner in primary care: the importance of allowing the cost of education and training when making decisions about changing the professional-mix. Journal of Nursing Management 15, 449-457.
76. Daumit G.L., Goldberg R.W., Anthony C., et al. (2005) Physical activity patterns in adults with severe mental illness. Journal of Nervous and Mental Disease 193, 641-646.
77. Davies C. (2000) Getting health professionals to work together. British Medical Journal 320, 1021-1022.
78. Dawson P.J. (1997) Is there anyone there? Psychiatric nursing meets biological psychiatry. Nursing Inquiry 4, 167-172.
79. Day J.C., Bentall R.P., Roberts C., et al. (2005a). Attitudes toward antipsychotic medication:the impact of clinical variables and relationships with health professionals. Archives of General Psychiatry 62, 717-724.
80. Day J.C., Wood G., Dewey M., et al. (1995b). A self-rating scale for measuring neuroleptic side effects. Validation in a group of schizophrenic patients. British Journal of Psychiatry 166, 650-653.
81. Dean B., Schachter M., Vincent C. et al. (2002) Causes of prescribing errors in hospital inpatients:a prospective study. The Lancet 359(315), 1373-1378.
82. Dementia UK (2007). Dementia UK. Project report. Alzheimer's Society, London.
83. Department of Health and Social Security (1986). Neighbourhood nursing: A focus for care. Report of the community nursing review (Cumberlege report). HMSO, London.
84. Dickerson F., Pater A. & Origoni A. (2002) Health behaviours and health status of older women with schizophrenia. Psychiatric Services 53(7), 882-884.
85. Disability Rights Commission (2006). Equal treatment: closing the gap. DRC. Accessed at:http://www.equalityhumanrights.com/Documents/Formal_investigations/HEALTH4.pdf.
86. DoH (1989). Report of the Advisory Group on Nurse Prescribing (Crown report). Department of Health, London.
87. DoH (1996a). The patients charter and you, a charter for England. HMSO, London.
88. DoH (1996b). Report of an independent survey of drug treatment services in England. The task force to review services for drug misusers. HMSO, London.
89. DoH (1999a). Review of prescribing, supply and administration of medicines. Final report. Department of Health, London.
90. DoH (1999b). Making a difference. HMSO, London.
91. DoH (1999c). A national service framework for mental health. Modern standards and service models. Stationary Office, London.
92. DoH (2000). The NHS plan. HMSO, London.
93. DoH (2001). The Journey to recovery -The government's vision for mental health care. HMSO, London.
94. DoH (2002). Mental health policy implementation guide: dual diagnosis good practice guide. Department of Health, London.
95. DoH (2003). Supplementary prescribing by nurses and pharmacists within the NHS in England. HMSO, London.
96. DoH (2004a). Achieving timely 'simple' discharge from hospital. HMSO, London.
97. DoH (2004b). Building a safer NHS for patients: improving medication safety. Department of Health, London.
98. DoH (2005a). Supporting people with long-term conditions. An NHS and social care model to support local innovation and integration. Department of Health, London.
99. DoH (2005b). New ways of working for psychiatrists. Final report 'But not the end of the story'. Department of Health, London.
100. DoH (2006a). Medicines matters: A guide to mechanisms for the prescribing, supply and administration of medicines. Department of Health, London.
101. DoH (2006b). Improving patients' access to medicines: a guide to implementing nurse and pharmacist independent prescribing within the NHS in England. Department of Health, London.
102. DoH (2006c). From values to action: the chief nursing officers review of mental health nursing. Department of Health, London.
103. DoH (2006d). Choosing health: supporting the physical health needs of people with serious mental illness. Department of Health, London.
104. DoH (2006e). Modernising nursing careers. National Assembly for Wales, Cardiff.
105. DoH (2007a). New ways of working for everyone -best practice toolkit. Department of Health, London.
106. DoH (2007b). Creating capable teams approach (CCTA). Best practice guidance to support the implementation of new ways of working and new roles. Department of Health, London.
107. DoH (2007c). Safe. Sensible. Social. The next steps in the National Alcohol Strategy. Department of Health, London.
108. DoH (2007d). A recipe for care -not a single ingredient. Department of Health, London.
109. DoH (2008a). Medicines management: everybody's business. Department of Health, London.
110. DoH (2008b). Mental Health Act 2007. Accessed at: http://www.dh.gov.uk/en/Healthcare/NationalServiceFrameworks/Mentalhealth/DH_078743
111. DoH (2008c). A high-quality workforce. NHS next stage review. Department of Health, London.
112. DoH (2008d). Supporting successful nurse prescribing. Department of Health, London.
113. DoH/CSIP (2007). Guidance statement on fidelity and best practice for crisis services. Department of Health, London.
114. Duncan L., Heathcote J., Djurdjev O. et al. (2001). Screening for renal disease using serum creatine:who are we missing? Nephrol Dial Transplant 16, 1042-1046.
115. El-Zayadi A.R. (2006) Heavy smoking and liver. World Journal of Gastroenterology 12, 6098-6101.
116. Farmer A., Korszun A. & Owen M.J. (2008) Medical disorders in people with recurrent depression. British Journal of Psychiatry 192, 351-355.
117. Fawcett B. & Karban K. (2005) Contemporary Mental Health: Theory, Policy and Practice. Routledge, London.
118. Felton A. & Stickey T. (2004) Pedagogy, power and service user involvement. Journal of Psychiatric and Mental Health Nursing 11, 89-98.
119. First M.B., Gibbon M., Spitzer R.L. et al. (1997) Structured Clinical Interview for DSM-IV Axis II Personality Disorder (SCID-II). American Psychiatric Press, Washington, DC.
120. Fisher S.E. & Vaughan-Cole B. (2003). Similarities and differences in clients treated and in medications prescribed by APRNs and psychiatrists in a CMHC. Archives of Psychiatric Nursing XVII(3), 101-107.
121. Fisher R. (2005) Relationships in nurse prescribing in district nursing practice in England: a preliminary investigation. International Journal of Nursing Practice 11(3), 102-107.
122. Fitzpatrick R. (1991) Surveys of patient satisfaction: 1 -Important general considerations. British Medical Journal 302(6781), 887-889.
123. Folstein M.F., Folstein S.E. & McHugh H.R. (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
124. Food Health Forum (2008). The links between diet and behaviour: the influence of nutrition on mental health. Report of an inquiry held by the Associate Parliamentary Food and Health Forum, HMSO.
125. Food Standards Agency (2004). Survey of caffeine levels in hot beverages. FSA. Accessed at:http://www.food.gov.uk.
126. Foucault M. (1974) The Order of Things. Tavistock, London.
127. Frances A., Pincus H.A. & First M.B. (1994) Diagnostic and Statistical Manual of Mental Disorder-IV. American Psychiatric Association, Washington.
128. Fredholm B.B., Battig K., Holmen J., et al. (1999) Actions of coffee in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews 51(1), 83-133.
129. Freeman A.J., Dore G.J., Law M.G., et al. (2001) Estimating progression in cirrhosis in chronic hepatitis C. Hepatology 34, 809-816.
130. Gallagher J., Ruskin A. & O'Gara C. (2006) Nurse prescribing in addiction services: client benefits. Nursing Standard 20, 42-44.
131. Garcia-Unzueta M.T., Herran A., Sierra-Biddle D., et al. (2003) Alterations of liver function tests in patients treated with antipsychotics. Journal of Clinical Laboratory Analysis 17, 216-218.
132. Garland M.R., Hallahan B., McNamara M., et al. (2007) Lipids and essential fatty acids in patients presenting with self-harm. British Journal of Psychiatry 190, 112-117.
133. Gask L. (2005) Role of specialists in common chronic diseases. British Medical Journal 330, 651-653.
134. Gee M. (2007). New ways of working threatens the future of the psychiatric profession. Psychiatric Bulletin 31, 315.
135. Gelder M., Mayou R. & Cowen P. (2004) Shorter Oxford Textbook of Psychiatry, Part 2. Oxford University Press, Oxford.
136. Gilmore I. & Sheron N. (2007) Reducing the harm of alcohol in the UK. British Medical Journal 335, 1271-1272.
137. Goldberg D. & Huxley P. (1992) Common Mental Disorders. Routledge, London.
138. Gooden J.M. & Jackson E. (2004) Attitudes of registered nurses towards nurse practitioners. Journal of the American Academy of Nurse Practitioners 16, 360-364.
139. Gossop M. & Moos R. (2008) Substance misuse among older adults: a neglected but treated problem. Addiction 103, 347-348.
140. Gough S.C.L. & O'Donovan M.C. (2005) Clustering of metabolic comorbidity in schizophrenia:a genetic contribution. Journal of Psychopharmacology 19, 47-55.
141. Gournay K. (1995) What to do with nursing models. Journal of Psychiatric and Mental Health Nursing 2, 325-327.
142. Granby T. (2007). Are you receiving appropriate support. Accessed at: http://www.npc.co.uk/presentations/trudy_afternoon.ppt
143. Grant G., Page D. & Maybury C. (2007) Introducing nurse prescribing in a memory clinic: staff experiences. Mental Health Nursing 27, 9-13.
144. Grantham G., McMillan V., Dunn S., et al. (2006) Patient self-medication -a change in hospital practice. Journal of Clinical Nursing 15(8), 962-970.
145. Gravel K., Legare F. & Graham I.D. (2006) Barriers and facilitators to implementing shared decision making in clinical practice: a systematic review of health professionals' perceptions. Implementation Science 1, 1-15.
146. Gray R., Leese M. & Bindman J. (2006) Adherence therapy for people with schizophrenia. British Journal of Psychiatry 189, 508-514.
147. Gray R., Parr A. & Robson D. (2005a). Has tardive dyskinesia disappeared? Mental Health Practice 8, 20-22.
148. Gray R., Parr A.-M. & Brimblecombe N. (2005b). Mental health nurse supplementary prescribing:mapping process 1 year after implementation. Psychiatric Bulletin 29, 295-297.
149. Gray R., Rofail D., Allen J., et al. (2005c). A survey of patient satisfaction with and subjective experience of treatment with antipsychotic medication. Journal of Advanced Nursing 52, 31-37.
150. Gray R., Wykes T. & Edmonds M. (2004) Effect of a medication management training package for nurses on clinical outcomes for patients with schizophrenia. British Journal of Psychiatry 185, 157-162.
151. Gray R., Wykes T. & Gournay K. (2002) From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing 9, 227-284.
152. Greenberg G.A., Myer J., Sernyak M., et al. (2006) Access of behavioural health patients to prescribing professionals. General Hospital Psychiatry 28, 249-254.
153. Greenwood N., Key A., Burns T., et al. (1999) Satisfaction with inpatient psychiatric services:relationship to patient and treatment factors. British Journal of Psychiatry 174, 159-163.
154. Griffiths S.R. (1988) Community care: agenda for action. HMSO, London.
155. Guillaume L., Cooper R., Avery A., et al. (2008) Supplementary prescribing by community and primary care pharmacists: an analysis of PACT data, 2004-2006. Journal of Clinical Pharmacy and Therapeutics 33, 11-16.
156. Haddock G., Barrowclough C., Tarrier N., et al. (2003) Cognitive behavioural therapy and motivational intervention for schizophrenia and substance misuse. British Journal of Psychiatry 183, 418-426.
157. Haddock G. (1994). Delusion Rating Scale. www.mentalhealthnurse.co.uk/images/Assessment%20Tools
158. Hall J., Cantrill J. & Noyce P. (2006). Why don't trained community nurse prescribers prescribe? Journal of Clinical Nursing 15(4), 403-412.
159. Hamann J., Langer B., Busch R et al. (2004) Medical decision making in antipsychotic drug choice. American Journal of Psychiatry 161, 1301-1304.
160. Hamblet C. (2000) Obstacles to defining the role of the nurse. Nursing Standard 14, 34-37.
161. Hamilton B., Manias E., Maude P., et al. (2004) Perspectives of a nurse, a social worker and a psychiatrist regarding patient assessment in acute inpatient psychiatry settings: a case study approach. Journal of Psychiatric and Mental Health Nursing 11, 683-689.
162. Happell B., Pinikahana J. & Roper C. (2002) Attitudes of postgraduate nursing students towards consumer participation in mental health services and the role of the consumer academic. International Journal of Mental Health Nursing 11, 240-250.
163. Harborne G. & Jones A. (2008) Supplementary prescribing: a new way of working for psychiatrists and nurses. Psychiatric Bulletin 32, 136-139.
164. Harniman B. (2007) Personal reflections on non-medical prescribing in substance misuse. Nurse Prescribing 5, 211-213.
165. Harris N., Lovell K. & Day J.C. (2007) Mental health practitioner's attitude towards maintenance neuroleptic treatment for people with schizophrenia. Journal of Psychiatric and Mental Health Nursing 14(2), 113-119.
166. Harrison A. (2003) Mental health service users' views of nurse prescribing. Nurse Prescribing 1, 78-85.
167. Havard A., Teeson M., Darke S., et al. (2006) Depression among heroin users: 12-month outcomes from the Australian treatment outcome study (ATOS). Journal of Substance Abuse Treatment 30, 355-362.
168. Hay A., Bradley E. & Nolan P. (2004) Supplementary nurse prescribing. Nursing Standard 18(41), 33-9.
169. Haynes R.B., McKibbon K.A., Kanani R. (1996) Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet 348(9024), 383-386.
170. Healthcare Commission (2006). Acute hospital portfolio reviews 2005-2006. Guide to medicines management in trusts providing mental health services. Accessed at: http://www. healthcarecommission.org.uk
171. Healthcare Commission (2007a). Acute inpatient mental health service review. Accessed at:http://www.healthcarecommission.org.uk
172. Healthcare Commission (2007b). Talking about medicines: the management of medicines in trusts providing mental health services. Commission for Healthcare Audit and Inspection, London. Accessed at: http://www.healthcarecommission.org.uk
173. Healy D. (2005) Psychiatric Drugs Explained. Elsevier, Edinburgh.
174. Helgason L. (1990) Twenty years' follow-up of first psychiatric presentation for schizophrenia:what could have been prevented? Acta Psychiatrica Scandinavica 81(3), 231-235.
175. Hemingway S. (2004) The mental health nurse's perspective on implementing nurse prescribing. Nurse Prescribing 2(1), 37-44.
176. Hemingway S. & Davies J. (2005). Non-medical prescribing education: how do we meet the needs of the diverse nursing specialisms? Nurse Prescriber 2, e58, doi:10.1017/S1467115805000581.
177. Hennekens C., Hennekens A., Hollar D., et al. (2005) Schizophrenia and increased risks of cardiovascular disease. American Heart Journal 150(6), 1115-1121.
178. Himelhoch S., Lehman A., Kreyenbuhl J., et al. (2004) Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. American Journal Psychiatry 161, 2317-2319.
179. Hobson R.J. & Sewell G.J. (2006) Risks and concerns about supplementary prescribing: survey of primary and secondary care pharmacists. Pharmacy World & Science 28, 76-90.
180. Holt R.I. (2005) Obesity -an epidemic of the twenty-first century: an update for psychiatrists. Journal of Psychopharmacology 19(6), 6-15.
181. Home Office (2001). The misuse of Drugs Regulations 2001. Statutory Instrument 2001, No. 3998. Accessed at: http://www.opsi.gov.uk/si/si2001/20013998.htm
182. Horrocks S., Anderson E. & Salisbury C. (2002) Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors. British Medical Journal 324, 819-823.
183. Horton R. (2002). Nurse-prescribing in the UK: right but also wrong. Lancet 359, 1875.
184. Howard P.B. & Greiner D. (1997) Constraints to advanced psychiatric-mental health nursing practice. Archives of Psychiatric Nursing 11(4), 198-209.
185. Institute of Medicine (1995). Weighing the Options: Criteria for Evaluating Eight Management Programmes. National Academy Press, Washington.
186. ICN (2004). Implementing Nurse Prescribing: An Updated Review of Current Practice Internationally. ICN, Geneva.
187. Jacobs J.T. (2005). Treatment of depressive disorders in split versus integrated therapy and comparisons of prescriptive practices of psychiatrists and advanced practice registered nurses. Archives of Psychiatric Nursing 12, 256-63
188. Jack B. & Merriman A. (2008) Dying without pain: nurses giving morphine in Uganda. European Journal of Palliative Care 15, 92-95.
189. Jagwe J. & Merriman A. (2007) Uganda: delivering analgesia in rural Africa: opioid availability and nurse prescribing. Journal of Pain and Symptom Management 33, 547-551.
190. Joint British Society (2005). JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 91, 1-52.
191. Jones A. (2006a). Acute psychiatric inpatient wards. Nurse Prescriber e0, 1-5, doi:10.1017/S1467115806000010.
192. Jones A. (2006b). Multidisciplinary team working: collaboration and conflict. International Journal of Mental Health Nursing 15, 19-28.
193. Jones A. (2006c). Supplementary prescribing: relationships between nurses and psychiatrists on hospital psychiatric wards. Journal of Psychiatric and Mental Health Nursing 13, 3-11.
194. Jones A. (2006d). Supplementary prescribing: potential ways to reform hospital psychiatric care. Journal of Psychiatric and Mental Health Nursing 13, 132-138.
195. Jones A. (2006e). Born in the USA. Mental Health Practice 9(6), 44.
196. Jones M. (2007) Psychopharmacology for nurse prescribers. Nurse Prescribing Conference Report. Surrey and Borders NHS Trust (Unpublished report).
197. Jones A. (2008) Exploring independent nurse prescribing for mental health settings. Journal of Psychiatric and Mental Health Nursing 15, 109-117.
198. Jones A., Doyle V., Pyke S., et al. (2005) New roles for nurses and psychiatrists in the management of long-term conditions. Mental Health Practice 9(3), 16-20.
199. Jones A. & Harborne G. (2005) Supplementary prescribing in hospital settings. Mental Health Practice 9, 38-40.
200. Jones A. & Jones M. (2005) Mental health nurse prescribing: issues for the UK. Journal of Psychiatric and Mental Health Nursing 12, 527-535.
201. Jones A. & Jones M. (2008a). Helping people on acute wards to stop smoking. Mental Health Practice 11, 18-21.
202. Jones C., Cormac I., Silveira da Mota Neto J.I., et al. (2004). Cognitive behaviour therapy for schizophrenia. The Cochrane Database of Systematic Reviews, Issue 4. Art No.: CD000524.1 0.1002/14651858.CD000524.pud2.
203. Jones M. (2004) Nurse prescribing: a case study in policy influence. Journal of Nursing Management 12, 266-272.
204. Jones M., Bennett J., Lucas B., et al. (2007) Mental health nurse prescribing: experiences of mental health nurses, psychiatrists and patients. Journal of Advanced Nursing 58(6), 1-9.
205. Jones M. & Jones A. (2006) Prescribing new ways of working. Mental Health Practice 9(6), 20-22.
206. Jones M. & Jones A. (2007a). Choice as an intervention to promote well-being: the role of the nurse prescriber. Journal of Psychiatric and Mental Health Nursing 15, 75-81.
207. Jones M. & Jones A. (2007b). Delivering the choice agenda as a framework to manage adverse effects: a mental health nurse perspective on prescribing psychiatric medication. Journal of Psychiatric and Mental Health Nursing 14, 418-423.
208. Jones M. & Jones A. (2008b). Promotion of choice in the care of people with bipolar disorder:a mental health nursing perspective. Journal of Psychiatric and Mental Health Nursing 15, 87-92.
209. Jordan S., Tunnicliffe C. & Sykes A. (2002) Minimizing side effects: the clinical impact of nurse-administered 'side effect' checklist. Journal of Advanced Nursing 37(2), 155-165.
210. Jordan S., Knight J. & Pointon D. (2004) Monitoring adverse drug reactions: scales, profiles, and checklists. International Nursing Review 51, 208-221.
211. Kaas M.J., Dahl D., Dehn D., et al. (1998) Barriers to prescriptive practice for psychiatric/mental health clinical nurse specialists. Clinical Nurse Specialist 12(5), 200-204.
212. Kaas M.J., Dehn D., Dahl D., et al. (2000). A view of prescriptive practice collaboration: perspectives of psychiatric mental health clinical nurse specialists and psychiatrists. Archives of Psychiatric Nursing XIV(5), 222-234.
213. Kaas M.J. & Markley J.M. (1998) A national perspective on prescriptive authority for advanced practice psychiatric nurses. Journal of American Psychiatric Nurses Association 4(6), 190-198.
214. Kaplan L. & Brown M.A. (2007) The transition of nurse practitioners to changes in prescriptive authority. Journal of Nursing Scholarship 39, 184-190.
215. Katon W., von Korff M., Lin E., et al. (2001) Rethinking practitioner roles in chronic illness:the specialist, primary care physician, and the practice nurse. General Hospital Psychiatry 23, 138-144.
216. Kavanagh D.J., Greenaway L., Jenner L., et al. (2000) Contrasting views and experience of health professionals on the management of comorbid substance misuse and mental disorders. Australian and New Zealand Journal of Psychiatry 34, 279-289.
217. Kemp R., Hayward P. & Applewhaite G. (1996) Compliance therapy in psychotic patients: randomised controlled trial. British Medical Journal 312, 345-349.
218. King R.L. (2004) Nurses' perceptions of their pharmacology educational needs. Journal of Advanced Nursing 45(4), 392-400.
219. Koenig H.G. & Blazer D.G. (1992) Epidemiology of geriatric affective disorders. Clinical Geriatric Medicine 8, 235-251.
220. Koplan K.E., David S.P. & Rigotti N.A. (2008). Smoking cessation. British Medical Journal 336, 217.
221. Lam D.H. & Wong G. (1997) Prodromes, coping strategies, insight and social functioning in biopolar affective disorder. Psychological Medicine 27, 1091-1100.
222. Lammers J. & Happell B. (2004) Mental health reforms and their impact on consumer and carer participation: a perspective from Victoria. Issues in Mental Health Nursing 25, 261-276.
223. Lanceley A., Savage J., Menon U., et al. (2008) Influences on multidisciplinary team decision making. International Journal of Gynaecological Cancer 18(2), 215-222.
224. Latter S. (2005). Promoting concordance in prescribing interactions: the evidence base and implications for the new generation of prescribers. In: M. Courtney & M. Griffiths (Eds.). Independent and Supplementary Prescribing: An Essential Guide. University Press, Cambridge.
225. Latter S. & Courtenay M. (2004) Effectiveness of nurse prescribing: a review of the literature. Journal of Clinical Nursing 13, 26-32.
226. Latter S., Maben J., Myall M., et al. (2005) An Evaluation of Extended Formulary Independent Nurse Prescribing. University of Southampton, Southampton.
227. Latter S., Maben J., Myall M., et al. (2007) Evaluating prescribing competencies and standards used in nurse independent prescribers' prescribing consultations. Journal of Research in Nursing 12, 7-26.
228. Laungani P. (2002) Mindless psychiatry and dubious ethics. Counselling Psychiatry Quarterly 15, 23-33.
229. Laurant M.G.H., Hermens R.P.M.G., Braspenning C.C., et al. (2004). Impact of nurse practitioners on workload of general practitioners: randomised controlled trial. British Medical Journal 328, 927.
230. Lawrence R., Bradshaw T. & Mairs H. (2006) Group cognitive behavioural therapy for schizophrenia:a systematic review of the literature. Journal of Psychiatric and Mental Health Nursing 13, 673-681.
231. Layard R. (2006) The depression report: a new deal for depression and anxiety disorders. Centre for Economic Performance, London School of Economics, London.
232. Lazaro F., Kulinskaya E. & Tobiansky R. (2001) Crisis intervention: the professionals' perspective. Psychiatric Bulletin 25, 95-98.
233. Leape L.L., Bates D.W., Cullen D.J. et al. (1995) Systems analysis of adverse drug events. ADE prevention study group. Journal of the American Medical Association 274(1), 35-43.
234. Leathard H.L. (2001) Understanding medicines: conceptual analysis of nurses needs for knowledge and understanding of pharmacology. Nurse Education Today 21, 260-271.
235. Lecompte D. & Pelc I. (1996) A cognitive-behavioural program to improve compliance with medication in patients with schizophrenia. International Journal of Mental Health 25(1), 51-56.
236. Lenton S. & Single E. (1998) The definition of harm reduction. Drugs and Alcohol Review 17, 213-220.
237. Leppard J. (2008) Running a clozapine clinic: considerations and challenges. Nurse Prescribing 6, 162-167.
238. Lewis-Evans A. & Jester A. (2004) Nurse prescribers' experiences of prescribing. Journal of Clinical Nursing 13, 796-805.
239. Lieberman J.A., Stroup T.S., McEvoy J.P., et al. (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353, 1209-1223.
240. Lim A.G., Honey M. & Kilpatrick J. (2007) Framework for teaching pharmacology to prepare graduate nurse for prescribing in New Zealand. Nurse Education Practice 7, 348-353.
241. Lim W.S., Gammack J.K., Niekerk J.K., et al. (2006). Omega-3 fatty acid for the prevention of dementia. Cochrane Database of Systematic Reviews 2006, Issue 1. Art No.: CD005379, doi:10.1002/14651858.CD005379.pub2.
242. Lingjaerde O., Ahlfors U.G., Bech S.J. et al. (1987). The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica 76, s334, 1-100.
243. Lockwood E.B. & Fealy G.M. (2008). Journal of Nursing Management Nurse prescribing as an aspect of future role expansion: the views of Irish clinical nurse specialists 16(7), 813-820.
244. Loh A., Leonhart R., Wills C.E., et al. (2007) The impact of patient participation on adherence and clinical outcome in primary care of depression. Patient Education and Counselling 65, 69-75.
245. Loh A., Simon D. & Hennig K. (2006) The assessment of depressive patients' involvement in decision making in audio taped primary care consultations. Patient Education and Counselling 63, 314-318.
246. Lupton D. (1997) Consumerism, reflexivity and the medical encounter. Social Science and Medicine 45(3), 373-381.
247. Luker K.A., Austin L., Willock J. et al. (1997) Nurses' and GP's views of the nurse prescribers' formulary. Nursing Standard 11(22), 33-38.
248. Luker K.A., Austin L., Hogg C., et al. (1998) Nurse-patient relationships: the context of nurse prescribing. Journal of Advanced Nursing 28, 235-242.
249. MacManus E. & Fitzpatrick C. (2007) Alcohol dependence and mood state in a population receiving methadone maintenance treatment. Irish Journal of Psychological Medicine 24, 19-22.
250. Makoul G., Arntson P. & Schofield T. (2005) Health promotion in primary care: physicianpatient communication and decision making about prescription medications. Social Science and Medicine 41(99), 1241-1254.
251. Malone D., Fineberg A.N. & Gale T.M. (2004) What is the usual length of stay in a psychiatric ward. International Journal of Psychiatry in Clinical Practice 8, 53-56.
252. Malone D., Marriott S., Newton-Howes G., et al. (2007). Community mental health teams (CMHTs) for people with severe mental illnesses and disordered personality. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD000270, doi:10.1002/14651858.CD000270.pub2.
253. Mason T., Carlisle C., Watkins C., et al. (2001) Stigma and social exclusion. Routledge, London.
254. McCann T. & Hemingway S. (2003) Models of prescriptive authority for mental health nurse practitioners. Journal of Psychiatric and Mental Health Nursing 10, 743-749.
255. McCann T.V. & Baker H. (2002) Community mental health nurses and authority to prescribe medications: the way forward. Journal of Psychiatric and Mental Health Nursing 9, 175-182.
256. McCann T.V., Baird J. & Lu S. (2008) Mental health professionals' attitude towards consumer participation in inpatient units. Journal of Psychiatric and Mental Health Nursing 15, 10-16.
257. McCann T.V. & Clark E. (2008) Attitudes of patients towards mental health nurse prescribing of antipsychotic agents. International Journal of Nursing Practice 14, 115-121.
258. McCreadie R.G. (2003) Diet, smoking and cardiovascular risk in people with schizophrenia. British Journal of Psychiatry 183, 534-539.
259. McCreadie R.G., Kelly C., Connolly M.A., et al. (2005) Dietary improvements in people with schizophrenia. British Journal of Psychiatry 187, 346-351.
260. McCreadie R.G., Macdonald E., Blacklock C., et al. (1998) Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study. British Medical Journal 317, 784-785.
261. McEvoy J.P., Apperson L.J., Applebaum P.S., et al. (1989) Insight in schizophrenia: its relationship to acute psychopathology. Journal of Nervous Mental Disorder 177, 43-47.
262. McGorry P.D. (2000). The scope for preventative strategies in early psychosis: logic, evidence and momentum. In: M. Birchwood, D. Fowler & C. Jackson (Eds.). Early Intervention in Psychosis: A Guide to Concepts, Evidence and Interventions, pp. 3-27. Wiley, Chichester.
263. McGraw C. & Drennan V. (2001) Self administration of medicine and older people. Nursing Standard 15(18), 33-36.
264. McIver S. (1999) Public involvement in primary care: implications for primary care groups. Nursing Times Research 4(4), 245-256.
265. McKinley R.K. & Middleton J.F. (1999) What do patients want from doctors? Content analysis of written patient agendas for the consultation. British Journal of General Practice 49, 796-800.
266. Meaney A.M. & O'Keane V. (2002) Prolactin and schizophrenia. Clinical consequences of hyperprolactinaemia. Life Sciences 71, 979-992.
267. Meier P.S., Barrowclough C. & Donmall M.C. (2005) The role of the therapeutic alliance in the treatment of substance misuse: a critical review of the literature. Addiction 100, 304-316.
268. Melia K.M. (1987) Learning and working: the occupational socialisation of nurses. Tavistock, London.
269. Meltzer H.Y. & Okayli G. (1995) Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. American Journal of Psychiatry 152(2), 183-190.
270. Menezes P.O., Johnson S., Thornicroft G., et al. (1996) Drug and alcohol problems among individuals with severe mental illness in South London. British Journal of Psychiatry 168, 612-619.
271. Meyer J.C., Summers R.S. & Moller H. (2001) Randomised, controlled trial of prescribing training in a South African province. Medical Education 35, 833-840.
272. Miles K., Seitio O. & McGilvray M. (2006) Nurse prescribing in low-resource settings: professional considerations. International Nursing Review 53, 290-296.
273. Miller W.R. & Rollnick S. (2004) Talking oneself into change: motivational interviewing, stages of change, and therapeutic process. Journal of Cognitive Psychotherapy 18, 299-308.
274. Moncrieff J. (1997). Psychiatric imperialism: the medicalisation of modern living [reprinted from Soundings, Issue 6, Summer]. Lawrence and Wishart, London.
275. Moos R., Brennan P., Schutte K., et al. (2004) High-risk alcohol consumption and late-life alcohol use problems. American Journal of Public Health 94, 1985-1991.
276. Moussavi S., Chatterji S., Verdes E., et al. (2007) Depression, chronic diseases, and decrements in health: results from the world health surveys. Lancet 370, 851-858.
277. Munro A., Watson H.E. & McFayden A. (2007) Assessing the impact of training on mental health nurses' therapeutic attitudes and knowledge about co-morbidity: a randomised controlled trial. International Journal of Nursing Studies 44, 1430-1438.
278. Murray A. (2007) Nurse prescribing in older person's mental health. Nurse Prescribing 5, 401-407.
279. Murray C.J. & Lopez A.D. (1996) Evidence-based health policy -lessons from the global burden of disease study. Science 274, 740-743.
280. National Audit Office (2006). Prescribing in primary care. Understanding what shapes GPs' prescribing choices and how might these be changed. RAND Corporation, Santa Monica.
281. National Audit Office (2001). Tackling obesity in England. The Stationary Office, London.
282. National Collaborating Centre for Mental Health (2004). Self-harm: The short-term physical and psychological management and secondary prevention of self-harm in primary and secondary care. Royal College of Psychiatrists, London.
283. NHS LA (2008) National Health Service Litigation Authority Report and Accounts2008. Office of Public Sector Information, Surrey.
284. National Institute of Mental Health in England (NIMHE) (2006). National suicide prevention strategy for England. Annual report on progress 2005. NIMHE, Leeds.
285. National Nursing and Nursing Education Taskforce (2006a). Myth Busters. Accessed at: http://www.nnet.gov.au/downloads/mythbusters_np.pdf
286. National Nursing and Nursing Education Taskforce (2006b). National Nurse Prescribing Glossary. Australian Health Ministers' Advisory Council. Accessed at: http://www.nnet.gov. au/downloads/n3et_national_nurse_prescribing_glossary.pdf.
287. National Obesity Forum (2008). Guidelines on management of adult obesity and overweight in primary care. Accessed at: http://www.nationalobesityforum.org.uk
288. National Patient Safety Agency (NPSA) (2006). With Safety in Mind: Mental Health Services and Patient Safety. Patient Safety Observatory Report (Mental Health) July 2006. NPSA, London.
289. National Prescribing Centre (2003). Maintaining competency in prescribing -an outline framework to help nurse supplementary prescribers (update). Accessed at: http://www.npc.nhs.uk
290. National Prescribing Centre (2004). Patient group directions. A practical guide and framework of competencies for all professionals using patient group directions. Accessed at: www.npc. nhs.uk
291. National Prescribing Centre (2005a). Improving mental health services by extending the role of nurses in prescribing and supplying medication: good practice guide. NPC, Liverpool.
292. National Prescribing Centre (2005b). Training non-medical prescribers in practice. NPC, Liverpool.
293. National Prescribing Centre (2005c). Results of surveying non-medical prescribers. Accessed at:http://www.npc.co.uk/non_medical/Survey_Results_2005.pdf
294. National Prescribing Centre (2007). A competency framework for shared decision-making with patients: achieving concordance about taking medicines. Accessed at: National Prescribing Centre (2008). Moving towards personalising medicines management: improving outcomes for people through the safe and effective use of medicines. Accessed at: http://www.npc.nhs.uk
295. National Treatment Agency (2007). Drug misuse and dependence. Guidelines on clinical management. NTA, London.
296. New Zealand Ministry of Health (1997). Report of the working group advising on the quality and safety issues associated with extending limited prescribing rights to registered nurses:report to the director-general of health. New Zealand Ministry of Health, Wellington..
297. New Zealand Ministry of Health (1998). Consultation document: nurse prescribing in aged care and child family health. New Zealand Ministry of Health, Wellington.
298. Ngcongco V.N. & Stark R.D. (1986) The development of a family nurse practitioner programme in Botswana. International Nursing Review 33(1), 9-14.
299. NICE (2002a). Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical Guideline No. 1, December 2002. NICE, London.
300. NICE (2002b). Guidance for the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. Technology Appraisal Guidance No. 43, June 2002. NICE, London.
301. NICE (2002c). Nicotine replacement therapy and bupropion for smoking cessation. NICE, London.
302. NICE (2004a). Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. Technology Appraisal 77. NICE, London.
303. NICE (2004b). Eating disorders: core interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. NICE, London.
304. NICE (2005). The short-term management of disturbed/violent behaviour in psychiatric inpatient settings and emergency departments. NICE, London.
305. NICE (2006a). Dementia: supporting people with dementia and their carers in health and social care. NICE/SCIE, London.
306. NICE (2006b). Depression: management of depression in primary and secondary care. Report No. CG23. NICE, London.
307. NICE (2006c). Bipolar disorder. NICE, London.
308. NICE (2006d). Smoking cessation. NICE, London.
309. NICE (2007a). Donepezil, galantamine, rivastigmine, and memantine for Alzheimer's disease. NICE, London.
310. NICE (2007b). Methadone and buprenorphine for the management of opioid dependence. NICE, London.
311. NICE (2008). Smoking cessation services in primary care, pharmacies, local authorities and workplaces, particularly for manual working groups, pregnant women and hard to reach communities. NICE, London.
312. Nilsson M. (1994). Opposition to nurse prescribing in Sweden. Lancet 344, 1077.
313. Nirodi P. & Mitchell A.J. (2002) The quality of psychotropic drug prescribing in patients in psychiatric units for the elderly. Ageing and Mental Health 6, 191-196.
314. Noble L.M., Douglas B.C. & Newman S.P. (2001) What do patients expect of psychiatric services? A systematic and critical review of empirical studies. Social Science and Medicine 52(7), 985-998.
315. Nolan P. (1998) A History of Mental Health Nursing. Nelson Thornes. ISBN 0748737219.
316. Nolan P. & Bradley E. (2007) The role of the nurse prescriber: the views of mental health and non-mental health nurses. Journal of Psychiatric and Mental Health Nursing 14, 258-266.
317. Nolan P., Haque M.S., Badger F., et al. (2001) Mental health nurses' perceptions of nurse prescribing. Journal of Advanced Nursing 36, 527-534.
318. North West Medicines Information Centre (2006). Which medicines need dose adjustment when a patient stops smoking. NWMIC, Liverpool.
319. Nose M., Barbui C. & Tansella M. (2003) How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychological Medicine 33, 1149-1160.
320. Nursing & Midwifery Council (2006). Standards of proficiency for nurse and midwife prescribers. NMC, London.
321. Nursing & Midwifery Council (2007). Standards for medicines management. Accessed at: http://www.nmc-uk.org
322. Nursing & Midwifery Council (2008). Guidance for Continuing Professional Development for Nurse and Midwife Prescribers. Accessed at: http://www.nmc-uk.org
323. O'Brien L. & Cole R. (2004) Mental health nursing practice in acute psychiatric close-observation areas. International Journal of Mental Health Nursing 13, 89-99.
324. O'Donnell C., Donohoe G., Sharkey L. et al. (2003) Compliance therapy: randomised controlled trial in schizophrenia. British Medical Journal 327(7419), 834-836.
325. O'Keefe C.D., Noordsy D.L., Liss T.B., et al. (2003) Reversal of antipsychotic-associated weight gain. Journal of Clinical Psychiatry 64, 907-912.
326. O'Shea E. (1999) Factors contributing to medication errors: a literature review. Journal of Clinical Nursing 8, 496-504.
327. Onyett S. (2002) Teamworking in Mental Health. Palgrave Macmillan, Hampshire.
328. Onyett S., Heppleston T. & Bushnell D. (1994) A national survey of community mental health teams. Team structure and process. Journal of Mental Health 3, 175-194.
329. Opie A. (1997) Thinking teams thinking clients: issues of discourse and representation in the work of health care. Sociology of Health & Illness 19, 259-280.
330. Otway C. (2002) The development needs of nurse prescribers. Nursing Standard 16, 33-38.
331. Patel M.X., DeZotsa N., Baker D., et al. (2005) Antipsychotic depot medication and attitudes of community psychiatric nurses. Journal of Psychiatric and Mental Health Nursing 12, 237-244.
332. Patterson M. & Hayes S. (1977) Verbal communication between students in multidisciplinary teams. Medical Education 11, 205-209.
333. Pekkala E. & Merinder L. (2003). Psychoeducation for Schizophrenia. Cochrane Database of Systematic Reviews, Issue 4. The Cochrane Library, UK.
334. Perkins D.O., Gu H., Boteva K., et al. (2005) Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. American Journal of Psychiatry 162, 1785-1804.
335. Phillips S.J. (2005) A comprehensive look at the legislative issues affecting advanced nursing practice. The Nurse Practitioner 30(1), 14-18.
336. Poole R. & Bhugra D. (2008). Should psychiatry exist? International Journal of Social Psychiatry 54, 195-196.
337. Poole R. & Higgo R. (2006) Psychiatric interviewing and assessment. Cambridge University Press, Cambridge.
338. Porter R. (2002) Madness: A Brief History. Oxford University Press, Oxford.
339. Public Citizen (2001). Rx R&D Myths: The Case Against the Drug Industry's R&D 'Scare Card'. Public Citizen's Congress Watch, Washington, D.C.
340. Ramcharan P., Hemingway S. & Flowers K. (2001) A client-centred care for nurse prescribing. Mental Health Nursing 21(5), 6-11.
341. Ranney L., Melvin C., Lux L., et al. (2006) Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Annals of Internal Medicine 145, 845-856.
342. Reason J. (1990) Human Error. Cambridge University Press, Cambridge.
343. Rethink (2006). Stigma and health services. Accessed at: http://www.rethink.org/living_with_ mental_illness/everyday_living/stigma_mental_illness/stigma_and_1.html
344. Rice V.H. & Stead L.F. (2008). Nursing interventions for smoking cessation. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD001188. DOI: 10.1002/14651858.CD001188.pub3.
345. Rigotti N.A., Munafo M.R. & Stead L.F. (2007). Interventions for smoking cessation in hospitalised patients. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.:CD001837.DOI:10.1002/14651837.pub2.
346. Rihs M., Muller C. & Baumann P. (1996) Caffeine consumption in hospitalised psychiatric patients. European Arch Psychiatry Clinical Neurosciences 246, 83-92.
347. Ritchie J., Dick D. & Lingham R. (1994) The report of the inquiry into the care and treatment of Christopher clunis. HMSO, London.
348. Rogers A. & Pilgrim D. (1994) Service users' views of psychiatric nurses. British Journal of Nursing 3(1), 16-18.
349. Rollnick S., Mason P. & Butler C. (2000) Health Behaviour Change: A Guide for Practitioners. Churchill Livingstone, Edinburgh.
350. Rose D. (2001) Users' Voices: The Perspectives of Mental Health Service Users on Community and Hospital Care. SCMH, London.
351. Royal College of Nursing (2007). A Joint statement on continuing professional development (CPD) for health and social care practitioners. RCN, London.
352. Royal College of Psychiatrists (2002). Annual census of psychiatric staffing 2001. Occasional paper 54. RCP, London.
353. Royal College of Psychiatrists (2007). Accreditation for Acute Inpatients Mental Health Services (AIMS). Accessed at: http://www.rcpsych.ac.uk/AIMS
354. Running A., Kipp C. & Mercer V. (2006) Prescriptive patterns of nurse practitioners and physicians. Journal of the American Academy of Nurse Practitioners 18, 228-233.
355. Rutter M. & Quinton D. (1984) Parental psychiatric disorder: effects on children. Psychological Medicine 14, 853-880.
356. Ryan A.A. & Chambers M. (2000) Medication management and older patients: an individualised and systematic approach. Journal of Clinical Nursing 9, 732-741.
357. Ryan M.C.M. & Thakore J.H. (2002) Physical consequences of schizophrenia and its treatment. The metabolic syndrome. Life Sciences 71, 239-257.
358. Ryan-Woolley B., McHugh G. & Luker K.A. (2007) Prescribing by specialist nurses in cancer and palliative care: results of a national survey. Palliative Medicine 21, 273-277.
359. Saari K., Koponen H., Laitinen J., et al. (2004) Hyperlipidaemia in persons using antipsychotic medication: a general population-based birth cohort study. Journal of Clinical Psychiatry 65, 547-550.
360. Sainsbury Centre for Mental Health (2001). The capable practitioner. SCMH, London.
361. Sainsbury Centre for Mental Health (2003). The search for acute solutions: a project to improve and evaluate acute mental health inpatient care. SCMH, London.
362. Sainsbury Centre for Mental Health (2005). Acute care: a national survey of adult psychiatric wards in England. SCMH, London.
363. Saitz R., Palfai T.N.F., Winter M.R., et al. (2007) Screening and brief interventions online for college students: the health study. Alcohol 42, 28-36.
364. Samson C. (1995) The fracturing of medical dominance in British psychiatry. Sociology of Health & Illness 17, 245-268.
365. Sawynok J. (1995) Pharmacological rationale for the clinical use of caffeine. Drugs 49, 37-50.
366. Schmidt I., Claesson C.B., Westerholm B., et al. (1998) The impact of regular multidisciplinary team interventions on psychotropic drugs in Swedish nursing homes. Journal of American Geriatric Society 46, 77-82.
367. Schou M. (1997) Forty years of lithium treatment. Archives of General Psychiatry 54, 9-13.
368. Scott J., Teasdale J.D., Paykel E.S., et al. (2000) Effects of cognitive therapy on psychological symptoms and social functioning in residual symptoms. British Journal of Psychiatry 177, 440-446.
369. Scull A.T. (1979) Museums of Madness: The Social Organization of Insanity in Nineteenthcentury England. Allen Lane.
370. Sernyak M., Leslie D., Alarcan R., et al. (2002) Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry 159, 561-566.
371. Shoptaw S., Rotheram-Fuller E., Yang X., et al. (2002) Smoking cessation in methadone maintenance. Addiction 97, 1317-1328.
372. Silverman K., Evans S.M., Strain E.C., et al. (1992) Withdrawal syndrome after the double-blind cessation of caffeine consumption. The New England Journal of Medicine 327, 1109-1114.
373. Silverstone T., Smith G. & Goodall E. (1988) Prevalence of obesity in patients receiving depot antipsychotics. British Journal of Psychiatry 153, 214-217.
374. Simpson G.M. & Angus J.W. (1970) A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 212, 11-19.
375. Siriwardena A.N. (2006) The rise and rise of non-medical prescribing. Quality in Primary Care 14(1), 1-3.
376. Skingsley D., Bradley E. & Nolan P. (2006) Neuropharmacology and mental health nurse prescribers. Journal of Clinical Nursing 15(8), 989-997.
377. Snowden A. (2007) Why mental health nurses should prescribe. Nurse Prescribing 5, 193-198.
378. Sodha M., McLaughlin M., Williams G., et al. (2002) Nurses' confidence and pharmacological knowledge: a study. British Journal of Community Nursing 7, 309-315.
379. Solomon D.A., Keller M.B. & Leon A.C. (2000) Multiple recurrence of major depressive disorder. American Journal of Psychiatry 157, 229-233.
380. Stahl S.M. (2000) Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 2nd edition. Cambridge University Press, Cambridge.
381. Stahl S.M. (2003). Primary care companion. Journal of Clinical Psychiatry 5(Suppl 3), 9-13.
382. Stahl S.M. (2006) Essential Psychopharmacology: The Prescribers Guide. Cambridge University Press, Cambridge.
383. Standing Nursing and Midwifery Advisory Committee (SNMAC) (1999). Mental health nursing:Addressing acute concerns. Report by the Standing Nursing and Midwifery Advisory Committee. Department of Health, London.
384. Stenner K. & Courntenay M. (2008) Benefits of nurse prescribing for patients in pain: nurses' views. Journal of Advanced Nursing 63, 27-35.
385. Sussman N. (2001) Review of atypical antipsychotics and weight gain. Journal of Clinical Psychiatry 62, 5-12.
386. Talley S. & Brooke P.S. (1992). Prescriptive authority for psychiatric clinical specialists: framing the issues. Archives of Psychiatric Nursing VI(2), 71-82.
387. Talley S. & Richens S. (2001). Prescribing practices of advanced practice psychiatric nurses: part 1 -demographic, educational and practice characteristics. Archives of Psychiatric Nursing XV(5), 205-213.
388. Tamminga C.A. & Lahti A.C. (1996) The new generation of antipsychotic drugs. International Clinical Psychopharmacology 11, 73-76.
389. Tanskanen A., Hibbeln J.R., Hintikka J., et al. (2001) Fish consumption, depression and suicidality in a general population. Archives of General Psychiatry 58, 512-513.
390. Taylor D., Paton C. & Kerwin R. (2007) Prescribing Guidelines, 9th edition. Taylor & Francis, London.
391. Thornicroft G. (2006). Perceptions by service users of healthcare staff. Accessed at: http://www. mentalhealthcare.org.uk/content/?id=191
392. Thornley B. & Adams C. (1998) Content and quality of 2000 controlled trials in schizophrenia over 50 years. British Medical Journal 317, 1181-1184.
393. Toma R., Jakovljevic T. & Brimblecombe N. (2008) Psychiatrists' and nurses' views of mental health nurse supplementary prescribing: a survey. Psychiatric Bulletin 32, 364-365.
394. Tompkins M. (2004) Using homework in psychotherapy: Strategies, Guidelines and Forms. The Guildford Press, London.
395. Tonna A.P., Steward D., West B., et al. (2007) Pharmacist prescribing in the UK -a literature review of current practice and research. Journal of Clinical Pharmacy and Therapeutics 32, 545-556.
396. Turner B.S. (1987) Medical power and social knowledge. Sage, London.
397. Turner D. (2002). Mapping the routes to recovery. Mental Health Today July, 29-30.
398. Tyrer P. & Steinberg D. (2005) Models for mental disorder. John Wiley & Sons, Chichester.
399. Usher K., Foster K. & McNamara P. (2005) Antipsychotic drugs and pregnant or breastfeeding women: issues for mental health nurses. Journal of Psychiatric and Mental Health Nursing 12, 713-718.
400. Ustun T.B., Ayuso-Matoes J.L., Chatterji S., et al. (2000) Global burden of depressive disorders in the year 2000. British Journal of Psychiatry 184, 386-392.
401. Ustun T.B. and Chatterji S. (2001). Global burden of depressive disorders and future projections. In: A. Dawson & A. Tylee (Eds.). Depression: Social and Economic Time Bomb. BMJ Books, London.
402. Venning P., Durie A., Roland M. et al. (2000) Randomised controlled trial comparing cost effectiveness of general practitioners and nurse practitioners in primary care. British Medical Journal 320, 1048-1053.
403. Vincent C., Neale G. & Woloshynowych M. (2001) Adverse events in British hospitals: preliminary retrospective review. British Medical Journal 322, 517-519.
404. Walburn J., Gray R., Gournay K., et al. (2001) Systematic review of patient and nurse attitudes to depot antipsychotic medication. British Journal of Psychiatry 179, 300-307.
405. Wand T. & White K. (2007) Progression of the mental health nurse practitioner role in Australia. Journal of Psychiatric and Mental Health Nursing 14, 644-651.
406. Wanless D. (2002) Securing Our Future Health: Taking a Long-Term View. Her Majesty's Treasury, London.
407. Welch R. & Chue P. (2000) Antipsychotic agents and QT changes. Journal of Psychiatry Neurosciences 25, 154-160.
408. Wells J., Gooney M., Bergen J., et al. (In press). Views on nurse prescribing -a report of a survey of community mental health nurses in the Republic of Ireland. Journal of Psychiatric and Mental Health Nursing.
409. While A.E. & Biggs K.S.M. (2004) Benefits and challenges of nurse prescribing. Journal of Advanced Nursing 45, 559-567.
410. Whiting J. (2007) Nursing the homeless: health care on the streets. Nurse Prescribing 11, 485-487.
411. Wieck A. & Haddad P.M. (2003) Antipsychotic-induced hyperprolactinaemia in women:pathophysiology, severity and consequences. British Journal of Psychiatry 182, 199-204.
412. Wilhelmsson S. & Foldevi M. (2003) Exploring views on Swedish district nurses' prescribing -a focus group study in primary health care. Journal of Clinical Nursing 12(5), 643-650.
413. Wilkinson G., Moore B. & Moore P. (1990) Treating People with Depression: A Practical Guide for Primary Care. Radcliffe Medical Press, Oxon.
414. Wilson J. (1996) A look up the scope. Nursing Management 2(8), 16-17.
415. Wing J.K., Cooper J.E. & Sartorius N. (1974) Measurement and Classification of Psychiatric Symptoms: An Instruction Manual for the PSE and the CATEGO Programme. Cambridge University Press, London.
416. Wirshing D.A., Pierre J.M., Erhart S.M., et al. (2003) Understanding the new and evolving profile of adverse drug effects in schizophrenia. Psychiatric Clinics of North America 26, 165-190.
417. Wittchen H.U. & Jacobi F. (2005) Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Neuropsychopharmacology 15, 357-376.
418. Wix S. (2007) Independent nurse prescribing in the mental health setting. Nursing Times 103, 30-31.
419. Wong F. & Chung L. (2006) Establishing a definition for a nurse-led clinic: structure, process, and outcome. Journal of Advanced Nursing 53, 358-369.
420. World Cancer Research Fund (2007). Food, nutrition, physical activity and the prevention of cancer: a global perspective. WCRF, London.
421. World Health Organisation (2001). Mental health: new understanding, new hope. World Health Organisation, Geneva.
422. World Health Organisation (2002). Reducing risks, promoting healthy life. World Health Organisation, Geneva.
423. World Health Organisation (2007). BMI classification. World Health Organisation, Geneva.
424. Wu M.-K., Wang C.-K., Bai Y.-C., et al. (2007) Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatric Services 58, 544-551.
425. Young R.C., Biggs J.T., Ziegler V.E., et al. (1978) A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry 133, 429-435.
426. Young Y. (2005) Lipids for psychiatrists -an overview. Journal of Psychopharmacology 19, 66-75.
427. Zimmet P., Alberti G. & Shaw J. (2005) A new IDF worldwide definition of the metabolic syndrome:the rationale and the results. Diabetes Voice 50, 31-33.
428. Zubin J. & Spring B. (1977) Vulnerability -a new view of schizophrenia. Journal of Abnormal Psychology 86, 103-124.
429. Zucconi M. & Ferini-Strambi L. (2004) Epidemiology and clinical findings of restless leg syndrome. Sleep Medicine 5(3), 293-299.
430. Zwarenstein M. & Reeves S. (2006) Knowledge translation and interprofessional collaboration:where the rubber of evidence-based care hits the road of teamwork. Journal of Continuing Education in the Health Professions 26, 46-54.